Literature DB >> 19223395

The BTB-MATH protein BATH-42 interacts with RIC-3 to regulate maturation of nicotinic acetylcholine receptors.

Anna Shteingauz1, Emiliano Cohen, Yoav Biala, Millet Treinin.   

Abstract

RIC-3 is a member of a conserved family of proteins that affect nicotinic acetylcholine receptor maturation. In yeast and in vitro, BATH-42, a BTB- and MATH-domain-containing protein, interacts with RIC-3. BATH-42 is also known to interact with the CUL-3 ubiquitin ligase complex. Loss of BATH-42 function leads to increased RIC-3 expression and decreased activity of nicotinic acetylcholine receptors in Caenorhabditis elegans vulva muscles. Increased expression of RIC-3 is deleterious for activity and distribution of nicotinic acetylcholine receptors, and thus the effects of BATH-42 loss of function on RIC-3 expression explain the associated reduction in receptor activity. Overexpression of BATH-42 is also detrimental to nicotinic acetylcholine receptor function, leading to decreased pharyngeal pumping. This effect depends on the C-terminus of RIC-3 and on CUL-3. Thus, our work suggests that BATH-42 targets RIC-3 to degradation via CUL-3-mediated ubiquitylation. This demonstrates the importance of regulation of RIC-3 levels, and identifies a mechanism that protects cells from the deleterious effects of excess RIC-3.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223395     DOI: 10.1242/jcs.036343

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  9 in total

1.  Ric-3 promotes alpha7 nicotinic receptor assembly and trafficking through the ER subcompartment of dendrites.

Authors:  John K Alexander; Daphna Sagher; Arcadius V Krivoshein; Manuel Criado; Gregory Jefford; William N Green
Journal:  J Neurosci       Date:  2010-07-28       Impact factor: 6.167

Review 2.  Astrocytic and microglial nicotinic acetylcholine receptors: an overlooked issue in Alzheimer's disease.

Authors:  Saeed Sadigh-Eteghad; Alireza Majdi; Javad Mahmoudi; Samad E J Golzari; Mahnaz Talebi
Journal:  J Neural Transm (Vienna)       Date:  2016-06-04       Impact factor: 3.575

3.  Impacts of chronic low-level nicotine exposure on Caenorhabditis elegans reproduction: identification of novel gene targets.

Authors:  Michael A Smith; Yanqiong Zhang; Joseph R Polli; Hongmei Wu; Baohong Zhang; Peng Xiao; Mary A Farwell; Xiaoping Pan
Journal:  Reprod Toxicol       Date:  2013-06-02       Impact factor: 3.143

4.  Xenopus laevis RIC-3 enhances the functional expression of the C. elegans homomeric nicotinic receptor, ACR-16, in Xenopus oocytes.

Authors:  Hayley M Bennett; Kristin Lees; Kate M Harper; Andrew K Jones; David B Sattelle; Susan Wonnacott; Adrian J Wolstenholme
Journal:  J Neurochem       Date:  2012-10-10       Impact factor: 5.372

5.  RIC-3 exclusively enhances the surface expression of human homomeric 5-hydroxytryptamine type 3A (5-HT3A) receptors despite direct interactions with 5-HT3A, -C, -D, and -E subunits.

Authors:  Jutta Walstab; Christian Hammer; Felix Lasitschka; Dorothee Möller; Christopher N Connolly; Gudrun Rappold; Michael Brüss; Heinz Bönisch; Beate Niesler
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

6.  RIC-3 phosphorylation enables dual regulation of excitation and inhibition of Caenorhabditis elegans muscle.

Authors:  Gracia Safdie; Jana F Liewald; Sarah Kagan; Emil Battat; Alexander Gottschalk; Millet Treinin
Journal:  Mol Biol Cell       Date:  2016-08-03       Impact factor: 4.138

7.  Mutation in histone deacetylase HDA-3 leads to shortened locomotor healthspan in Caenorhabditis elegans.

Authors:  Kazuto Kawamura; Ichiro N Maruyama
Journal:  Aging (Albany NY)       Date:  2020-12-03       Impact factor: 5.682

Review 8.  Speculation on How RIC-3 and Other Chaperones Facilitate α7 Nicotinic Receptor Folding and Assembly.

Authors:  Ralph H Loring
Journal:  Molecules       Date:  2022-07-15       Impact factor: 4.927

9.  RIC-3 expression and splicing regulate nAChR functional expression.

Authors:  Yael Ben-David; Tehila Mizrachi; Sarah Kagan; Tamar Krisher; Emiliano Cohen; Talma Brenner; Millet Treinin
Journal:  Mol Brain       Date:  2016-04-29       Impact factor: 4.041

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.